EBS logo

Emergent BioSolutions Inc.

EBS
Healthcare|Drug Manufacturers - Specialty & Generic|US
$6.06
+0.21 (+3.59%)
DCF Value
$3.57
Tangible Book / Share
$1.18
Cash / Share
$3.42
Next Earnings Report
Feb 25, 2027
EPS est. -$0.16 · Revenue est. $137.5M
Financing Filings (last 12 months)
0
No shelf registrations or offering prospectuses filed.

Upcoming Data Readouts (0)

No upcoming completion dates found in active trials.

Recent Press Releases

Emergent BioSolutions Receives $22.3 Million Delivery Order Modification to Supply BioThrax® (Anthrax Vaccine Adsorbed) to the U.S. Department of War
Nov 4, 2026 · Business Wire
Emergent Biosolutions Reports Third Quarter 2026 Financial Results
Nov 2, 2026 · Business Wire
Emergent BioSolutions Announces Retirement of Chief Financial Officer Richard S. Lindahl
Oct 16, 2026 · Business Wire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Emergent BioSolutions Inc. - EBS
Sep 24, 2026 · PRNewsWire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Emergent BioSolutions Inc. - EBS
Sep 22, 2026 · GlobeNewsWire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Emergent BioSolutions Inc. - EBS
Sep 17, 2026 · PRNewsWire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Emergent BioSolutions Inc. - EBS
Sep 15, 2026 · GlobeNewsWire
Media Advisory: Emergent to Host Ribbon Cutting Ceremony at Canton Manufacturing Facility
Sep 15, 2026 · GlobeNewsWire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Emergent BioSolutions Inc. - EBS
Sep 8, 2026 · GlobeNewsWire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Emergent BioSolutions Inc. - EBS
Sep 3, 2026 · PRNewsWire

SEC Filings (72)

Last two years from EDGAR. Insider Form 4s are on the Ownership tab.

FiledFormWhat it isLinks
Nov 4, 20268-KMaterial eventDocumentIndex
Nov 3, 202610-QQuarterly reportDocumentIndex
Nov 2, 20268-KMaterial eventDocumentIndex
Oct 16, 20268-KMaterial eventDocumentIndex
Sep 14, 20268-KMaterial eventDocumentIndex
Sep 1, 20268-KMaterial eventDocumentIndex
Aug 14, 2026SC 13GPassive 5%+ stakeDocumentIndex
Aug 6, 202610-QQuarterly reportDocumentIndex
Aug 5, 20268-KMaterial eventDocumentIndex
Jul 31, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Jul 28, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Jun 29, 20268-KMaterial eventDocumentIndex
May 1, 202610-QQuarterly reportDocumentIndex
Apr 30, 2026S-8Employee stock planDocumentIndex
Apr 30, 20268-KMaterial eventDocumentIndex
Apr 30, 20268-KMaterial eventDocumentIndex
Apr 29, 2026SC 13GPassive 5%+ stakeDocumentIndex
Apr 28, 2026DEFA14AProxy / shareholder voteDocumentIndex
Apr 27, 2026DEFA14AProxy / shareholder voteDocumentIndex
Apr 22, 2026DEFA14AProxy / shareholder voteDocumentIndex
Apr 17, 20268-KMaterial eventDocumentIndex
Apr 16, 2026DEFA14AProxy / shareholder voteDocumentIndex
Apr 16, 2026DEFA14AProxy / shareholder voteDocumentIndex
Apr 9, 2026SC 13GPassive 5%+ stakeDocumentIndex
Mar 26, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Mar 20, 2026ARSAnnual report to holdersDocumentIndex
Mar 20, 2026DEFA14AProxy / shareholder voteDocumentIndex
Mar 20, 2026DEF 14AProxy / shareholder voteDocumentIndex
Mar 3, 20268-KMaterial eventDocumentIndex
Feb 27, 202610-KAnnual reportDocumentIndex
Feb 26, 20268-KMaterial eventDocumentIndex
Feb 9, 2026SC 13GPassive 5%+ stakeDocumentIndex
Jan 30, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Jan 14, 20268-KMaterial eventDocumentIndex
Jan 12, 20268-KMaterial eventDocumentIndex
Dec 12, 20258-KMaterial eventDocumentIndex
Nov 12, 20258-KMaterial eventDocumentIndex
Oct 30, 202510-QQuarterly reportDocumentIndex
Oct 29, 20258-KMaterial eventDocumentIndex
Sep 11, 20258-KMaterial eventDocumentIndex